Hepatitis D Differential Diagnoses

Author: Praveen K Roy, MD, AGAF; Chief Editor: Julian Katz, MD more...

Updated: Dec 2, 2011

What would you like to print?

Diagnostic Considerations

Conditions to consider in the differential diagnosis of hepatitis D, along with those in the next section, include the following:

Acetaminophen poisoning
Drug-induced hepatitis
Fatty liver of pregnancy
HELLP (hemolysis, elevated liver enzymes, and low platelet) syndrome in pregnant patients
Ischemic liver injury
Mushroom toxicity
Bile duct strictures
Biliary obstruction
Conjugated hyperbilirubinemia
Isoniazid hepatotoxicity

Differential Diagnoses

Proceed to Workup

Contributor Information and Disclosures

Author

Praveen K Roy, MD, AGAF Gastroenterologist, Ochsner Clinic Foundation; Adjunct Associate Research Scientist, Lovelace Respiratory Research Institute; Editor-in-Chief, The Internet Journal of Gasteroenterology; Editorial Board, Signal Transduction Insights; Editorial Board, The Internet Journal of Epidemiology; Editorial Board, Gastrointestinal Endoscopy Review Letter

Praveen K Roy, MD, AGAF is a member of the following medical societies: American College of Gastroenterology, American Gastroenterological Association, and American Society of Gastrointestinal Endoscopy

Disclosure: Nothing to disclose.

Coauthor(s)

Sean R Lacey, MD Associate Professor of Gastroenterology, Pennsylvania State University College of Medicine

Sean R Lacey, MD is a member of the following medical societies: American College of Gastroenterology, American College of Physicians, and American Gastroenterological Association

Disclosure: astra zenaca Honoraria Speaking and teaching

Chief Editor

Julian Katz, MD Clinical Professor of Medicine, Drexel University College of Medicine

Julian Katz, MD is a member of the following medical societies: American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, American Geriatrics Society, American Medical Association, American Society for Gastrointestinal Endoscopy, American Society of Law, Medicine & Ethics, American Trauma Society, Association of American Medical Colleges, and Physicians for Social Responsibility

Disclosure: Nothing to disclose.

Additional Contributors

David Eric Bernstein, MD Director of Hepatology, North Shore University Hospital; Professor of Clinical Medicine, Albert Einstein College of Medicine

David Eric Bernstein, MD is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, and American Society for Gastrointestinal Endoscopy

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

References

Rizzetto M, Verme G, et al. Delta hepatitis--present status. J Hepatol. 1985;1(2):187-93. [Medline].
Bean P. Latest discoveries on the infection and coinfection with hepatitis D virus. Am Clin Lab. Jun 2002;21(5):25-7. [Medline].
Xiridou M, Borkent-Raven B, Hulshof J, Wallinga J. How hepatitis D virus can hinder the control of hepatitis B virus. PLoS One. 2009;4(4):e5247. [Medline].
Smedile A, Casey JL, Cote PJ, et al. Hepatitis D viremia following orthotopic liver transplantation involves a typical HDV virion with a hepatitis B surface antigen envelope. Hepatology. Jun 1998;27(6):1723-9. [Medline].
Samuel D, Zignego AL, Reynes M, et al. Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis. Hepatology. Feb 1995;21(2):333-9. [Medline].
Romeo R, Del Ninno E, Rumi M, et al. A 28-year study of the course of hepatitis delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology. May 2009;136(5):1629-38. [Medline].
Heidrich B, Deterding K, Tillmann HL, Raupach R, Manns MP, Wedemeyer H. Virological and clinical characteristics of delta hepatitis in Central Europe. J Viral Hepat. Dec 2009;16(12):883-94. [Medline].
Makuwa M, Mintsa-Ndong A, Souquière S, Nkoghé D, Leroy EM, Kazanji M. Prevalence and molecular diversity of hepatitis B virus and hepatitis delta virus in urban and rural populations in northern Gabon in central Africa. J Clin Microbiol. Jul 2009;47(7):2265-8. [Medline]. [Full Text].
Wedemeyer H, Yurdaydìn C, Dalekos GN, Erhardt A, Çakaloglu Y, Degertekin H, et al. Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med. Jan 27 2011;364(4):322-31. [Medline].
Manesis EK, Schina M, Le Gal F, et al. Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring. Antivir Ther. 2007;12(3):381-8. [Medline].

View Table List